Expression and function of CD40 in rheumatoid arthritis synovium

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1048-1053

  Sekine, Chiyoko ^a   Yagita, Hideo ^a   Miyasaka, Nobuyuki ^a,b   Okumura, Ko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

CD40; Monocytes; Rheumatoid arthritis; Synovia; Tumor necrosis factor

Indexed keywords

CD40 ANTIGEN; CYTOKINE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE;

ADULT; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; ARTHRITIS, RHEUMATOID; CHO CELLS; CRICETINAE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MONOCYTES; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031856976     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Harris ED. Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
3. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
4. Suttles J, Miller RW, Tao X, Stout RD. T cells which do not express membrane tumor necrosis factor-α activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-α production. Eur J Immunol 1994;24:1736-42.
5. Stout RD, Bottomly K. Antigen-specific activation of effector macrophages by IFN-α producing (Th1) T cell clones. Failure of IL-4-producing (Th2) T cell clones to activate effector function in macrophages. J Immunol 1989;142:760-5.
6. Tao X, Stout RD. T cell-mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells. Eur J Immunol 1993;23:2916-21.
7. Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
8. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-74.
9. Caux C, Massacrier C, Vanbervlet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994;180:1263-72.
10. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober J. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995;92:4342-6.
11. Covey LR, Cleary AM, Yellin MJ, et al. Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4 T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Mol Immunol 1994;31:471-84.
12. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992;13:431-3.
13. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994;367:425-8.
14. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1994;1:167-78.
15. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-31.
16. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993;14:559-64.
17. Wanger DH, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 1994;24:3148-54.
18. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 1995;155:4917-25.
19. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996;156:8-11.
20. Wiley JA, Harmsen AG. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol 1995;155:3525-9.
21. Soong L, Xu J-C, Grewal IS, et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to leishmania amazonensis. Immunity 1996;4:263-73.
22. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to leishmania major. Immunity 1996;4:283-9.
23. Kamanaka M, P. Y, Yasui T, et al. Protective role of CD40 in leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275-81.
24. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993;261:1328-30.
25. Gerritse K, Laman JD, Noelle RJ, et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996;93:2499-504.
26. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in regulation of humoral and cell-mediated immunity. Immunol Today 1994;15:406-11.
27. Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996;17:487-92.
28. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-23.
29. Rissoan MC, Van Kooten C, Chomarat P, et al. The functional CD40 antigen of fibloblast may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996;106:481-90.
30. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
31. Inaba M, Inaba K, Fukuba Y, et al. Activation of thymic B cells by signals of CD40 molecules plus interleukin-10. Eur J Immunol 1995;25:1244-8.
32. Katira A, Holder M, Pound J, Gordon J. CD40 workshop panel report Oxford: Oxford University Press, 1995.
33. Kwekkeboom J, de Boer M, Tager JM, de Groot C. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. Immunology 1993;79:439-44.
34. Yellin MJ, Sippel K, Inghirami G, et al. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 1994;152:598-608.
35. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
36. Eliott MJ, Maini RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNF-α. Arthritis Rheum 1993;36:1681-90.
37. Eliott MJ, Maini RN, Feldmann M, et al. Randomised double blind comparison of a chimeric monoclonal antibody to tumor necrosis factor-α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
38. Rankin ECC, Choy EHS, Kassimos D, et al. The therapeutic effects of an engineered human anti-tumor necrosis factor alpha antibody (CD571) in rheumatoid arthritis. Br J Rheumatol 1995;34:334-42.
39. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
40. Miossec P, Chomarat P, Dechanet J. Bypassing the antigen to control rheumatoid arthritis. Immunol Today 1996;17:170-3.
41. Shu U, Kiniwa M, Wu CY, et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125-8.
42. Malik N, Greenfield BW, Wahl AF, Kiener PA. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 1996;156:3952-60.